Sugi Predict

Sugi Predict / Compounds / SCHEMBL710310

SCHEMBL710310

SCHEMBL710310

CC(C)Oc1ccc(OCc2ccccc2)cc1-c1nc2cc(C(=O)O)cnc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 4/20 0.47
▸ MCL1 Q07820 1/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ CSNK2A2 P19784 1/20 0.42
▸ CSNK2A1 P68400 1/20 0.42
▸ EDNRA P25101 1/20 0.41
▸ EGLN1 Q9GZT9 2/20 0.41
▸ P2RY14 Q15391 1/20 0.40
▸ CHEK2 O96017 1/20 0.40
▸ NR4A2 P43354 2/20 0.40
▸ SRD5A2 P31213 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711611 0.93 GCK (0.47) GCKMCL1PDE4APDE4BPDE4C
SCHEMBL710541 0.91 MAOB (0.47) GCKALDH1A1HPGDGABRPGABRD
SCHEMBL711368 0.90 XDH (0.41) GCKMCL1ALDH1A1KMT2A
SCHEMBL711045 0.87 EDNRA (0.39) GCKMCL1EDNRACHEK2KDM4E
SCHEMBL13639547 0.87 PDGFRB (0.39) GCKMCL1EDNRAGABRPGABRD
SCHEMBL10206516 0.87 MCL1 (0.41) MCL1PDE4BCHEK2KDM4EALDH1A1
SCHEMBL713174 0.86 MAOA (0.41) GCKMCL1EDNRACHEK2GABRP
SCHEMBL711734 0.86 GCK (0.39) GCKMCL1EDNRAALDH1A1GABRP
Trifluoroacetic Acid SCHEMBL711184 0.85 MCL1 (0.41) MCL1EDNRAEGLN1CHEK2GABRP
SCHEMBL712035 0.85 GYS1 (0.39) GCKMCL1EDNRACHEK2SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 — — EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 — — EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK GCK 1/4885MCL1 4054/4885PDE4A 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.